CNSY Cerenome, Inc.
Company Analysis
Latest News
🔴 Cerenome is trading 5.7% down amid broader healthcare weakness
Cerenome is trading 5.7% down at $1.65 on October 23, 2026, amid broader healthcare weakness, though no direct company-specific link is confirmed. - The...
🟢 Cerenome is trading 5.7% up in pre-market — catalyst remains unclear
Cerenome is trading at $1.85, up +5.71%, with no confirmed catalyst for the pre-market move. - No fresh company announcement dated October 23, 2026, was...
🟢 Cerenome is trading 6.55% up today with no confirmed catalyst
Cerenome is trading 6.55% up now at $1.79, with no confirmed catalyst identified for the October 21 move. - On October 21, Cerenome announced new preclinical...
🟢 Cerenome is trading 7% up today with no identified company-specific catalyst
Cerenome is trading at $1.77, up 7.27%, with no direct company catalyst identified. - No clear company-specific announcement explaining the October 20 move...
🔴 Cerenome is trading 5% down with no clear company-specific catalyst identified
Cerenome is trading 5.29% lower at $1.61, with no clear company-specific catalyst identified for the October 19, 2026 decline. - The latest reported company...
🔴 Cerenome is trading 6.9% down with no clear company-specific catalyst
Cerenome is trading 6.9% down at $1.75 on October 16, 2026, with no clear company-specific catalyst identified. - The latest identified company releases were...
🟢 Cerenome is trading 4.8% up in pre-market amid healthcare-sector strength
Cerenome is trading 4.8% up at $1.97 in pre-market, with healthcare-sector strength the clearest available context. - Compared with the October 15 close of...
🟢 Cerenome is trading 10.12% up today amid healthcare-sector strength
Cerenome is trading at $1.85, up 10.12%, with healthcare-sector strength offering the clearest available context; no clear company-specific announcement...
🟢 Cerenome is trading 6.6% up on October 15, 2026, amid healthcare-sector gains
Cerenome is trading at $1.79, up 6.55%, with healthcare-sector strength a possible tailwind. - Healthcare shares are rising amid inflation concerns and strong...
🔴 Cerenome is trading 6.2% down with no clear company-specific catalyst
Cerenome is trading 6.2% down at $1.63, with broader risk sentiment potentially contributing; no clear company-specific catalyst has been identified for...
🔴 Cerenome is trading 6.08% down with no clear company-specific catalyst
Cerenome is trading at $1.70, down 6.08%, with no clear company-specific catalyst identified during live trading on October 13, 2026. - Cerenome’s latest...
🔴 Cerenome is trading 6.2% down with no clear catalyst identified
Cerenome is trading 6.22% down at $1.81 as of 10:41 a.m. ET on October 12, 2026, with the specific driver unclear. - Molecular profile tests became available...
🔴 Cerenome is trading 5.7% down in pre-market — no clear company-specific catalyst found
Cerenome is trading at $1.82, with a -5.74% move in pre-market; no clear company-specific news was found to explain the decline. - Cerenome’s molecular...
🟢 Cerenome is trading 6% up today after Florida Blue added coverage for both tests
Cerenome is trading at $1.90, up 5.87%, following its October 8 announcement of a Florida Blue in-network agreement covering both tests. - The agreement adds...
Florida Blue Gives Cerenome Its Broadest Payer Deal Yet — But Can a $1.80 Stock Turn Insurance Wins Into Revenue?
Shares of Cerenome surged 10.1% to $1.80 on October 8, bucking a weak tape for healthcare stocks, after the company announced that Florida Blue — one of the...
🟢 Cerenome is trading 10% up today after Florida Blue covers both CNSide tests
Cerenome is trading at $1.80, up 10.09%, after announcing an in-network agreement with Florida Blue. - Announced October 8, 2026, the agreement covers CNSide...
🟢 Cerenome is trading 5% up today after Florida Blue deal covers both CNSide tests
Cerenome is trading at $1.72, up +5.18%, after announcing an in-network agreement with Florida Blue covering its CNSide tumor-cell and molecular-profile...
🟢 Cerenome is trading 10.1% up in pre-market with no clear company-specific catalyst identified
Cerenome is trading 10.1% up at $1.80 in pre-market on October 8, with no clear company-specific announcement identified to explain the move. - Shares closed...
🟢 Cerenome is trading 9.5% up in pre-market; no explaining announcement identified
Cerenome is trading 9.46% up at $1.79 in pre-market on October 8, with no new company announcement identified to explain the move. - Cerenome closed at $1.64...
🟢 Cerenome is trading 6.9% up as reason remains unclear
Cerenome is trading 6.9% higher at $1.70, with no clear catalyst identified. - No October 7 company announcement was identified. - An October 6 launch...